Nuclear Medicine Communications

Aims & Scope

Nuclear Medicine Communications, the official journal of the British Nuclear Medicine Society, is a rapid communications journal covering nuclear medicine and molecular imaging with radionuclides, and the basic supporting sciences.

As well as clinical research and commentary, manuscripts describing research on preclinical and basic sciences (radiochemistry, radiopharmacy, radiobiology, radiopharmacology, medical physics, computing and engineering, and technical and nursing professions involved in delivering nuclear medicine services) are welcomed, as the journal is intended to be of interest internationally to all members of the many medical and non-medical disciplines involved in nuclear medicine.

In addition to papers reporting original studies, frankly written editorials and topical reviews are a regular feature of the journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.3
2024	1.30

SJR (SCImago Journal Rank)

Year	Value
2024	0.393

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	83

Journal Rank

Year	Value
2024	13970

Journal Citation Indicator

Year	Value
2024	623

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• PET versus SPECT: strengths, limitations and challenges

  Citation: 645

  Authors: Arman, Habib

• 99Tcm sestamibi — a new agent for parathyroid imaging

  Citation: 329

  Authors: A. J., A. G., C. P., M. J., R. E.G.

• Guidelines for the measurement of glomerular filtration rate using plasma sampling

  Citation: 252

  Authors: John S., Maureen A., Glen M., Maria, Philip S.

• Radiology Review Manual

  Citation: 224

  Authors: Wolfgang

• A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

  Citation: 217

  Authors: K. K., J., J., S. J., P. J., K. E.

• 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction

  Citation: 168

  Authors: B B, Y, J WM, M F, R, D L

• Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology

  Citation: 162

  Authors: Paolo, Anna M., Maria, Tullio, Mohsen, Cristina, Cristina, Maria C., Giuseppe, Adil, Domenico, Ferruccio, Stefano

• FDG uptake, tumour characteristics and response to therapy

  Citation: 152

  Authors: T. A. D.

• Review of functional/anatomical imaging in oncology

  Citation: 147

  Authors: Stephanie N., Maria L., Esther, Baris, Peter L., Karen A.

• Subtraction ictal SPET co-registered to MRI in partial epilepsy

  Citation: 146

  Authors: TJ., M. K., B. P., B. H., D., C. R., E. L.

---